BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao R, Lv Y, Feng T, Zhang R, Ge L, Pan J, Han B, Song G, Wang L. ATF6α promotes prostate cancer progression by enhancing PLA2G4A-mediated arachidonic acid metabolism and protecting tumor cells against ferroptosis. Prostate 2022. [PMID: 35089606 DOI: 10.1002/pros.24308] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou H, Zhang T, Chen L, Cui F, Xu C, Peng J, Ma W, Huang J, Sheng X, Liu M, Zhao F. The functional implication of ATF6α in castration-resistant prostate cancer cells. FASEB J 2023;37:e22758. [PMID: 36607288 DOI: 10.1096/fj.202201347R] [Reference Citation Analysis]
2 Alhasan B, Mikeladze M, Guzhova I, Margulis B. Autophagy, molecular chaperones, and unfolded protein response as promoters of tumor recurrence. Cancer Metastasis Rev 2023. [PMID: 36723697 DOI: 10.1007/s10555-023-10085-3] [Reference Citation Analysis]
3 Pan L, Gong C, Sun Y, Jiang Y, Duan X, Han Y, Wang Y. Induction mechanism of ferroptosis: A novel therapeutic target in lung disease. Front Pharmacol 2022;13:1093244. [PMID: 36569297 DOI: 10.3389/fphar.2022.1093244] [Reference Citation Analysis]
4 Huang L, Li T, Li M, Luo H, Wang Y, Wang J. Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells.. [DOI: 10.21203/rs.3.rs-2297771/v1] [Reference Citation Analysis]
5 Shrestha R, Nassar ZD, Hanson AR, Iggo R, Townley SL, Dehairs J, Mah CY, Helm M, Ghodsi M, Pickering M, Watt MJ, Quek L, Hoy AJ, Tilley WD, Swinnen JV, Butler LM, Selth LA. ACSM1 and ACSM3 regulate prostate cancer fatty acid metabolism to promote tumour growth and constrain ferroptosis.. [DOI: 10.1101/2022.10.13.511039] [Reference Citation Analysis]
6 Whitlock NC, White ME, Capaldo BJ, Ku AT, Agarwal S, Fang L, Wilkinson S, Trostel SY, Shi ZD, Basuli F, Wong K, Jagoda EM, Kelly K, Choyke PL, Sowalsky AG. Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A. Discov Oncol 2022;13:97. [PMID: 36181613 DOI: 10.1007/s12672-022-00565-3] [Reference Citation Analysis]
7 de la Calle CM, Shee K, Yang H, Lonergan PE, Nguyen HG. The endoplasmic reticulum stress response in prostate cancer. Nat Rev Urol 2022. [PMID: 36168057 DOI: 10.1038/s41585-022-00649-3] [Reference Citation Analysis]
8 Wen J, Aili A, Yan YX, Lai Y, Niu S, He S, Zhang X, Zhang G, Li J. OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism. Front Oncol 2022;12:977348. [DOI: 10.3389/fonc.2022.977348] [Reference Citation Analysis]
9 Wang Y, Ma Y, Jiang K. The role of ferroptosis in prostate cancer: a novel therapeutic strategy. Prostate Cancer Prostatic Dis 2022. [PMID: 36056183 DOI: 10.1038/s41391-022-00583-w] [Reference Citation Analysis]
10 Ji J, Li H, Wang W, Yuan B, Shen T. ARPC1A is regulated by STAT3 to inhibit ferroptosis and promote prostate cancer progression. Human Cell. [DOI: 10.1007/s13577-022-00754-w] [Reference Citation Analysis]
11 Yun D, Wang X, Wang W, Ren X, Li J, Wang X, Liang J, Liu J, Fan J, Ren X, Zhang H, Shang G, Sun J, Chen L, Li T, Zhang C, Yu S, Yang X. A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma. Front Oncol 2022;12:897702. [PMID: 35756689 DOI: 10.3389/fonc.2022.897702] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Whitlock NC, White ME, Capaldo BJ, Ku AT, Agarwal S, Fang L, Wilkinson S, Trostel SY, Shi Z, Basuli F, Wong K, Jagoda EM, Kelly K, Choyke PL, Sowalsky AG. Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A.. [DOI: 10.1101/2022.06.04.22276001] [Reference Citation Analysis]